Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Pharmacol ; 87(6): 936-53, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25769304

RESUMEN

G protein-coupled receptors, including the M3 muscarinic acetylcholine receptor, can form homo-oligomers. However, the basis of these interactions and the overall organizational structure of such oligomers are poorly understood. Combinations of site-directed mutagenesis and homogenous time-resolved fluorescence resonance energy transfer studies that assessed interactions between receptor protomers at the surface of transfected cells indicated important contributions of regions of transmembrane domains I, IV, V, VI, and VII as well as intracellular helix VIII to the overall organization. Molecular modeling studies based on both these results and an X-ray structure of the inactive state of the M3 receptor bound by the antagonist/inverse agonist tiotropium were then employed. The results could be accommodated fully by models in which a proportion of the cell surface M3 receptor population is a tetramer with rhombic, but not linear, orientation. This is consistent with previous studies based on spectrally resolved, multiphoton fluorescence resonance energy transfer. Modeling studies furthermore suggest an important role for molecules of cholesterol at the dimer + dimer interface of the tetramer, which is consistent with the presence of cholesterol at key locations in many G protein-coupled receptor crystal structures. Mutants that displayed disrupted quaternary organization were often poorly expressed and showed immature N-glycosylation. Sustained treatment of cells expressing such mutants with the muscarinic receptor inverse agonist atropine increased cellular levels and restored both cell surface delivery and quaternary organization to many of the mutants. These observations suggest that organization as a tetramer may occur before plasma membrane delivery and may be a key step in cellular quality control assessment.


Asunto(s)
Receptor Muscarínico M3/metabolismo , Atropina/farmacología , Membrana Celular/metabolismo , Colesterol/química , Agonismo Inverso de Drogas , Transferencia Resonante de Energía de Fluorescencia , Glicosilación , Células HEK293 , Humanos , Modelos Moleculares , Agonistas Muscarínicos/química , Agonistas Muscarínicos/farmacología , Antagonistas Muscarínicos/química , Mutagénesis Sitio-Dirigida , Regiones Promotoras Genéticas , Multimerización de Proteína , Transporte de Proteínas , Ensayo de Unión Radioligante , Receptor Muscarínico M3/química , Receptor Muscarínico M3/genética , Derivados de Escopolamina/química , Bromuro de Tiotropio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA